Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
Veids | Citi |
Valoda | EN |
Statuss | Publicēts |
Versija | |
Datums | 2014-12-09 15:53:26 |
Versijas komentārs | |
Teksts |
Olainfarm Holds Third Quarter 2014 Investor Conference Webinar JSC Olainfarm
invites shareholders, investors, mass media representatives and
other stakeholders to join its third quarter 2014 investor
conference webinar scheduled on December 9, 2014 at 16:00
(EET). Webinar will be
hosted by the member of the management board Salvis Lapiņš. The
presentation will be in English. During the webinar
Salvis Lapiņš will inform about JSC Olainfarm latest activities and
analyse the financial results of the third quarter 2014.
After the
presentation investors will be welcomed to ask
questions.
The enclosed presentation will be used during the
webinar. What is
webinar? How to join the
webinar? Additional
information on the webinar For more
information on webinar service please visit:
http://www.nasdaqbaltic.com/en/products-services/webinars-3/
JSC Olainfarm is one of the
biggest pharmaceutical companies in Latvia with more than 40 years
of experience in production of medication and chemical and
pharmaceutical products. A basic principle of company's operations
is to produce reliable and effective top quality products for
Latvia and the rest of the world. Products made by the Group are
being exported to more than 35 countries of the world, including
the Baltics, Russia, other CIS, Europe, Asia, North America and
Australia Information
prepared by: |
Pielikumi |